Trimeprazine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01246 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 19 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | allergic urticaria | KG + DL |
| 2 | cold urticaria | KG + DL |
| 3 | IgE responsiveness, atopic | KG + DL |
| 4 | nasal cavity disease | KG + DL |
| 5 | recalcitrant atopic dermatitis | KG + DL |
| 6 | acute laryngopharyngitis | KG + DL |
| 7 | bronchial disease | KG + DL |
| 8 | endobronchial leiomyoma | KG + DL |
| 9 | endobronchial lipoma | KG + DL |
| 10 | bronchus adenoma | KG + DL |
| 11 | autoimmune urticaria | KG + DL |
| 12 | anorectal stricture | KG + DL |
| 13 | urticaria, aquagenic | KG + DL |
| 14 | trigeminal autonomic cephalalgia | KG + DL |
| 15 | myopia X-linked | KG + DL |
| 16 | headache disorder | KG + DL |
| 17 | imperforate anus | KG + DL |
| 18 | anal polyp | KG + DL |
| 19 | myopia 26, X-linked, female-limited | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.